Oral GS-441524 Tablets 20mg 40mg 50mg 60mg For FIP In Cats With Stable Antiviral Formula

Oral GS-441524 Tablets 20mg 40mg 50mg 60mg for FIP in Cats with Stable Antiviral Formula

Product Description

GS-441524 tablets are an oral antiviral formulation developed for feline use, especially in cases related to feline infectious peritonitis (FIP). As a nucleoside analog compound, it acts by interfering with the viral RNA replication process, helping to suppress the spread of infection at the cellular level.

Compared with injectable forms, oral tablets offer a more convenient administration option for long-term use. This makes them particularly suitable for home care, multi-cat environments, and situations where stress from injections needs to be minimized.

In practical veterinary applications, GS-441524 has been widely recognized for its role in managing FIP-related conditions, supporting recovery and improving overall survival outcomes in cats.

Product Features & Specifications

• Precisely formulated for oral administration
• Stable composition with reliable bioavailability
• Multiple strength options to meet different needs
• Easy to store and transport
• Suitable for continuous dosing protocols

Technical Parameters

Functional Benefits & Advantages

GS-441524 functions by mimicking natural nucleosides, allowing it to integrate into viral RNA chains and terminate replication prematurely. This targeted mechanism helps:

• Limit viral load within the body
• Slow down disease progression
• Support immune system response
• Improve stability during long-term treatment cycles

Additionally, the tablet form provides:

• Stress-free administration compared to injections
• Better compliance for long treatment durations
• Flexible use in daily feeding routines

Understanding Feline Infectious Peritonitis (FIP)

FIP is a complex viral condition in cats caused by a mutated form of feline coronavirus (FCoV). While many cats may carry the virus without issue, certain mutations can trigger a severe immune-mediated disease.

Key Points:

• Cause: Mutation of feline coronavirus
• Transmission: Common in shared living environments through contamination
• Types:
  • Wet form (fluid accumulation in abdomen/chest)
  • Dry form (organ-related inflammation)

Common Signs:

• Persistent fever
• Weight loss and low appetite
• Lethargy and weakness
• Breathing difficulty (in wet cases)
• Possible neurological or eye involvement

Due to its complex nature, FIP often requires comprehensive evaluation and ongoing management.

Application & Usage Guidance

• Recommended Dosage: 10mg per kg of body weight
• Administration: Oral intake, can be given directly or mixed with food
• Timing: Suitable before or after meals, preferably at a fixed time daily
• Treatment Duration: Commonly recommended for approximately 12 weeks

Note: Usage should follow professional veterinary guidance based on individual conditions.

Packaging & Shipping

• Standard packaging: 10 tablets per bag
• Secure sealing to maintain product quality
• Flexible shipping arrangements based on order quantity
• Stable supply for both small and bulk orders